MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Metabolomic Analysis of Fecal Matter from Parkinsonian Mice

    V. Vedam-Mai, E. Gill, J. Koelmel, R. Yost, T. Garrett, M. Okun (Gainesville, FL, USA)

    Objective: Assess the metabolic changes in fecal matter in mice treated with an immunomodulatory therapy. Background: The cause of neuronal death in Parkinson’s disease (PD)…
  • 2019 International Congress

    The effects of timed exposure to bright light in improving the gait patterns of patients with Parkinson’s disease – A pilot study

    L. Alibiglou, T. Ruopp (Tehran, Islamic Republic of Iran)

    Objective: To investigate the impact of timed exposure to bright light (TEBL) on improving gait function in medicated PD patients with dyskinesias (PD+DYS) and without…
  • 2019 International Congress

    The Efficacy and Safety of Subcutaneous Apomorphine in Patients with Parkinson’s Disease: A Meta-Analysis Randomized Controlled Trials

    M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

    Objective: The objective of this study to evaluate the efficacy and safety of subcutaneous apomorphine for patients with Parkinson’s disease (PD). Background: Subcutaneous apomorphine has…
  • 2019 International Congress

    Abnormal Intracortical Facilitation in patients of Parkinson’s disease with REM Sleep Behavior Disorder

    A. Bhattacharya, N. Kamble, R. Yadav, PK Pal

    Objective: To evaluate the motor cortical excitability changes in PD patients with and without RBD. Background: There has been an increase in the understanding of…
  • 2019 International Congress

    Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study

    S. Castillo-Torres, C. Soto-Rincón, D. Cantú-García, A. Mendoza-Garcia, D. Díaz-Pérez, D. Martínez-Roque, B. Chávez-Luévanos, I. Estrada-Bellmann, F. Góngora-Rivera (Monterrey, Mexico)

    Objective: To determine the clinical correlates of carotid intima media thickess in patients with idiopathic Parkinson’s disease (PD). Background: Subclinical cardiovascular disease has been suggested…
  • 2019 International Congress

    Quantitative straight and circular walking parameters for detecting ON and OFF medication states in early PD

    MF. Corrà, N. Vila-Chã, J. Damasio, S. Duarte, A. Sardoreira-Bràs, P. Salgado, M. Calejo, C. Hansen, H. Minh Pham, R. Magalhães, M. Correia, W. Maetzler, L. Maia (Porto, Portugal)

    Objective: To determine gait parameters that differentiate between ON and OFF medication states using mobile health technology (one device at the lower back) in a…
  • 2019 International Congress

    Factors Affecting Mortality in Late Stage Parkinson’s Disease

    S. Dempsey, L. Mcdonald, I. Sayers, WK. Gray, A. Hand, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the effect of dysphagia and hospital admissions on mortality in late stage Parkinson's disease. Background: Parkinson’s disease (PD) is a neurodegenerative condition…
  • 2019 International Congress

    Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aims to explore the expression profiles of lncRNA of PD patients and its roles to the pathogenesis of PD. Background: The molecular…
  • 2019 International Congress

    Accuracy of clinical diagnosis of atypical parkinsonism: comparison of consensus clinical criteria with MRI criteria

    D. Gwendoline, G. David, D. Bertrand, L. Stephane, C. Florence (Paris, France)

    Objective: Our study retrospectively analyzed the clinical and imaging data of 42 consecutive  patients with PS whose diagnosis was uncertain at an early stage. The…
  • 2019 International Congress

    Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson’s Disease and “OFF” Episodes: Post Hoc Analysis From a Phase 3 Study

    J. Hui, S. Fox, W. Neeson, P. Bhargava, E. Pappert, D. Blum, B. Navia (Los Angeles, CA, USA)

    Objective: To compare time to onset and magnitude of motor improvement following administration of apomorphine sublingual film (APL-130277; APL) vs levodopa in patients with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley